These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1554951)

  • 21. Strategies for fluoxetine-MAOI combination therapy.
    Peterson GN
    J Clin Psychiatry; 1991 Feb; 52(2):87-8. PubMed ID: 1993642
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of pethidine and morphine in the presence of monoamine oxidase inhibitors.
    Evans-Prosser CD
    Br J Anaesth; 1968 Apr; 40(4):279-82. PubMed ID: 5654977
    [No Abstract]   [Full Text] [Related]  

  • 23. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants.
    Murphy DL
    Adv Pharmacol Chemother; 1977; 14():71-105. PubMed ID: 18913
    [No Abstract]   [Full Text] [Related]  

  • 27. MONOAMINE OXIDASE INHIBITORS: A REVIEW.
    HASTINGS GE
    J Kans Med Soc; 1963 Sep; 64():409-18. PubMed ID: 14047794
    [No Abstract]   [Full Text] [Related]  

  • 28. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase inhibitors and weight gain.
    Cantú TG; Korek JS
    Drug Intell Clin Pharm; 1988 Oct; 22(10):755-9. PubMed ID: 3068037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VASCULAR CRISES ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS.
    BETHUNE HC; BURRELL RH; CULPAN RH; OGG GJ
    Am J Psychiatry; 1964 Sep; 121():245-8. PubMed ID: 14233735
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of MAOI antidepressants.
    Ravaris CL; Robinson DS; Nies A; Ives JO; Bartlett D
    Am Fam Physician; 1978 Jul; 18(1):105-11. PubMed ID: 665471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAOIs - does the evidence warrant their resurrection?
    Menkes D; Bosanac P; Castle D
    Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B; Foote B; Walsh BT; Roose SP
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine oxidase inhibitors, combined with thymoleptics: Are they really unusable for human beings?
    Bartonícek VJ
    Pharmacology; 1970; 4(2):80-90. PubMed ID: 5528371
    [No Abstract]   [Full Text] [Related]  

  • 37. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression.
    Van den Eynde V; Abdelmoemin WR; Abraham MM; Amsterdam JD; Anderson IM; Andrade C; Baker GB; Beekman ATF; Berk M; Birkenhäger TK; Blackwell BB; Blier P; Blom MBJ; Bodkin AJ; Cattaneo CI; Dantz B; Davidson J; Dunlop BW; Estévez RF; Feinberg SS; Finberg JPM; Fochtmann LJ; Gotlib D; Holt A; Insel TR; Larsen JK; Mago R; Menkes DB; Meyer JM; Nutt DJ; Parker G; Rego MD; Richelson E; Ruhé HG; Sáiz-Ruiz J; Stahl SM; Steele T; Thase ME; Ulrich S; van Balkom AJLM; Vieta E; Whyte I; Young AH; Gillman PK
    CNS Spectr; 2022 Jul; ():1-14. PubMed ID: 35837681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of monoamine oxidase inhibitor-induced hypomania.
    Cohen R; Pickar D
    Arch Gen Psychiatry; 1978 Nov; 35(11):1393-4. PubMed ID: 708198
    [No Abstract]   [Full Text] [Related]  

  • 39. Disruption of FR-40 by 5-HT agonists. II. Effects of chronic phenelzine or isocarboxazid.
    Shukla R; Goudreau J; Mackenzie-Taylor D; Rech RH
    Pharmacol Biochem Behav; 1989 Oct; 34(2):283-7. PubMed ID: 2622983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
    Naylor MW; Grunhaus L; Cameron O
    J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.